Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T- and B-cell immunity after virosome-based influenza vaccination (Inflexal V) in allogeneic HSCT recipients
2013-003403-19Phase 4Completed
- Sponsor
- Karolinska University Hospital
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Inflexal V in influenza, sponsored by Karolinska University Hospital. Primary endpoint: B-cell response. Started Aug 2013; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-003403-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003403-19.